- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Hikal Limited — Updates, 06-08-2026: Press Release
06-08-2026 | 04:38 pm
06-08-2026 | 04:38 pm
Hikal's Q1FY27 revenue hit ₹403 Cr (+6.2% YoY), EBITDA ₹37 Cr (+47.4%). Pharma saw recovery (+15.2%) with new cGMP plant. Crop Protection's CDMO was soft, but Own Products grew. Personal Care business commercialized. US FDA remediation is ongoing.
No comments yet. Be the first to comment!